PATENT CLAIM ANALYSIS

Application Number: 16301240
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "115000"]

Abstract:
The present invention relates to compounds for use in the prevention and/or treatment of PAR-related diseases, such as for example: pain and ocular disorders. More in particular, the present invention provides bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of pancreatitis-related pain, IBS (irritable bowel syndrome), IBD (inflammatory bowel disease), dry eye disease and conjunctivitis sicca. These inhibitors were found to have a different inhibitory profile compared to diphenyl guanidinophenylethylphosphonates leading to a more pronounced effect on these conditions.

Claim (Index 25):
The bis(acetamidophenyl) guanidinophenylethylphosphonate compound of  claim 16 , wherein the PAR-related disorder is an ocular disease selected from the group consisting of dry eye syndrome, meibomian gland dysfunction blepharitis, rosaceous, allergies, scarring from glaucoma medications, chemical burns, thermal burns, immunological conditions, Mucous Membrane Pemphigoid, and Sjogren's Syndrome.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13543022', '11722952', '13997979', '15309195', '12176279']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7997700334886279
- 35 USC 102 Novelty (BERT): 0.4857376535162786
- Combined Prediction Score: 0.7683667954913929
- Mean Citation Score: 213.648352
- Max Citation Score: 226.32257
- Similarity Product: 177.3729347355199

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test